SEARCH
CONTACT US
NingboLinstant Polymer Materials Co., Ltd.,
No.777 Binhai 4th Road Hangzhou Bay New Area, Ningbo,Zhejiang province,P.R.CHINA 315336
Tel: 13989315696
Fax: 86-0574-58966735
E-mail: transong@linstant.cn
Website : www.linstant.cn
MESSAGES
Copyright © 2018 Ningbo Linstant Polymer Materials Co.,Ltd All rights reserved 浙ICP备15004068号 Powered by 300.cn
ACC 2017 Late-Breaking Trials
Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presented at ACC.17 March 17-19, in Washington, D.C. The studies are linked to articles specific to the trial presentations. ACC.17 Opening Showcase and the Joint ACC/JACC Late-Breaking Clinical Trials
Friday, March 17
• FOURIER: Primary Results of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial
• SPIRE 1 and SPIRE 2: Safety and Cardiovascular Event Efficacy of Bococizumab Among 27,000 High-risk Patients
• SURTAVI: Transcatheter Aortic Valve Replacement With a Self-Expanding Bioprosthesis Compared With Surgical Aortic Valve Replacement in Patients at Intermediate Surgical Risk: First Results From the SURTAVI Clinical Trial
Friday, March 17
• FOURIER: Primary Results of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial
• SPIRE 1 and SPIRE 2: Safety and Cardiovascular Event Efficacy of Bococizumab Among 27,000 High-risk Patients
• SURTAVI: Transcatheter Aortic Valve Replacement With a Self-Expanding Bioprosthesis Compared With Surgical Aortic Valve Replacement in Patients at Intermediate Surgical Risk: First Results From the SURTAVI Clinical Trial